These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 26681215)

  • 41. Meta-analysis of the relationship between slow acetylation of N-acetyl transferase 2 and the risk of bladder cancer.
    An Y; Li H; Wang KJ; Liu XH; Qiu MX; Liao Y; Huang JL; Wang XS
    Genet Mol Res; 2015 Dec; 14(4):16896-904. PubMed ID: 26681036
    [TBL] [Abstract][Full Text] [Related]  

  • 42. N-acetyltransferase 2 (NAT2) genotypes, cigarette smoking, and the risk of breast cancer.
    Alberg AJ; Daudt A; Huang HY; Hoffman SC; Comstock GW; Helzlsouer KJ; Strickland PT; Bell DA
    Cancer Detect Prev; 2004; 28(3):187-93. PubMed ID: 15225898
    [TBL] [Abstract][Full Text] [Related]  

  • 43. GST, NAT, SULT1A1, CYP1B1 genetic polymorphisms, interactions with environmental exposures and bladder cancer risk in a high-risk population.
    Hung RJ; Boffetta P; Brennan P; Malaveille C; Hautefeuille A; Donato F; Gelatti U; Spaliviero M; Placidi D; Carta A; Scotto di Carlo A; Porru S
    Int J Cancer; 2004 Jul; 110(4):598-604. PubMed ID: 15122594
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of genotypes of carcinogen-activating enzymes, phenol sulfotransferase SULT1A1 (ST1A3) and arylamine N-acetyltransferase NAT2, with urothelial cancer in a Japanese population.
    Ozawa S; Katoh T; Inatomi H; Imai H; Kuroda Y; Ichiba M; Ohno Y
    Int J Cancer; 2002 Dec; 102(4):418-21. PubMed ID: 12402313
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Association Between NAT2 Polymorphisms and Lung Cancer Susceptibility.
    Liu C; Cui W; Cong L; Wang L; Ruan X; Jia J; Liu Y; Jia X; Zhang X
    Medicine (Baltimore); 2015 Dec; 94(49):e1947. PubMed ID: 26656326
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A meta-analysis of the relationship between NAT2 polymorphism and colorectal cancer susceptibility.
    Liu H; Fu ZX; Wang CY; Qian J; Xing L; Liu YW
    Medicina (Kaunas); 2012; 48(3):117-31. PubMed ID: 22588343
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Joint effect of polymorphism in the N-acetyltransferase 2 gene and smoking on hepatocellular carcinoma.
    Zhang J; Xu F; Ouyang C
    Tumour Biol; 2012 Aug; 33(4):1059-63. PubMed ID: 22293947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-acetyltransferase 2 gene polymorphisms are associated with susceptibility to cancer: a meta-analysis.
    Tian FS; Shen L; Ren YW; Zhang Y; Yin ZH; Zhou BS
    Asian Pac J Cancer Prev; 2014; 15(14):5621-6. PubMed ID: 25081676
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of NAT2 phenotype with risk of head and neck carcinoma: A meta-analysis.
    Zheng Y; Li Y; Teng Y; Zhang Z; Cao X
    Oncol Lett; 2012 Feb; 3(2):429-434. PubMed ID: 22740926
    [TBL] [Abstract][Full Text] [Related]  

  • 50. NAT1 polymorphisms and cancer risk: a systematic review and meta-analysis.
    Zhang K; Gao L; Wu Y; Chen J; Lin C; Liang S; Su J; Ye J; He X
    Int J Clin Exp Med; 2015; 8(6):9177-91. PubMed ID: 26309576
    [TBL] [Abstract][Full Text] [Related]  

  • 51. N-acetyltransferase 2 genetic variants confer the susceptibility to head and neck carcinoma: evidence from 23 case-control studies.
    Zhang L; Xiang Z; Hao R; Li R; Zhu Y
    Tumour Biol; 2014 Apr; 35(4):3585-95. PubMed ID: 24338712
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Association Between NAT2 Polymorphism and Lung Cancer Risk: A Systematic Review and Meta-Analysis.
    Zhu K; Xu A; Xia W; Li P; Zhang B; Jiang H; Zhou S; Wang R
    Front Oncol; 2021; 11():567762. PubMed ID: 33777732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. NAT2 polymorphisms with oral carcinoma susceptibility: a meta-analysis.
    Zhuo XL; Ling JJ; Zhou Y; Zhao HY; Song YF; Tan YH
    Mol Biol Rep; 2012 Sep; 39(9):8813-9. PubMed ID: 22722991
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The association of NAT1 polymorphisms and colorectal carcinoma risk: evidence from 20,000 subjects.
    Cai J; Zhao Y; Zhu CL; Li J; Huang ZH
    Mol Biol Rep; 2012 Jul; 39(7):7497-503. PubMed ID: 22327651
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Absence of association between N-acetyltransferase 2 acetylator status and colorectal cancer susceptibility: based on evidence from 40 studies.
    Zhang Lq; Zhou Jn; Wang J; Liang Gd; Li Jy; Zhu Yd; Su Yt
    PLoS One; 2012; 7(3):e32425. PubMed ID: 22403658
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Relationship between NAT2 polymorphisms and onset risk of acute leukemia: a systematic review and meta-analysis.
    Jiang WH; Wang XT; Zheng LD; Yan QQ; Chen LL
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9259-9266. PubMed ID: 31773677
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Risks on N-acetyltransferase 2 and bladder cancer: a meta-analysis.
    Zhu Z; Zhang J; Jiang W; Zhang X; Li Y; Xu X
    Onco Targets Ther; 2015; 8():3715-20. PubMed ID: 26715854
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Association between selenium intake and the risk of pancreatic cancer: a meta-analysis of observational studies.
    Wang L; Wang J; Liu X; Liu Q; Zhang G; Liang L
    Biosci Rep; 2016 Oct; 36(5):. PubMed ID: 27623938
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bayesian analysis on meta-analysis of case-control studies accounting for within-study correlation.
    Chen Y; Chu H; Luo S; Nie L; Chen S
    Stat Methods Med Res; 2015 Dec; 24(6):836-55. PubMed ID: 22143403
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Genetic susceptibility: significance in risk assessment.
    Portier CJ; Bell DA
    Toxicol Lett; 1998 Dec; 102-103():185-9. PubMed ID: 10022252
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.